Related Experiment Video
Updated: May 20, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus
C C Shen1, H T Chung, Y L Huang
1Division of Allergy, Asthma, and Rheumatology, Department of Paediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Insights
Children with childhood-onset systemic lupus erythematosus (SLE) have larger coronary arteries. Higher serum uric acid (UA) levels, earlier age at diagnosis, and increased body mass index (BMI) are linked to these enlarged arteries.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Pediatrics
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems.
- Cardiovascular complications, including coronary artery disease (CAD), are a significant concern in patients with SLE.
- Paediatric-onset SLE may have unique risk factors and disease trajectories compared to adult-onset SLE.
Purpose of the Study:
- To compare coronary artery dimensions in children with SLE versus healthy controls.
- To identify risk factors associated with increased coronary artery dimensions in paediatric SLE patients.
Main Methods:
- Cross-sectional analysis of 83 children with SLE and 36 healthy controls.
- Echocardiographic measurement of coronary artery diameters.
- Assessment of body mass index (BMI), blood pressure, serum uric acid (UA), creatinine, and lupus-related factors.
Main Results:
- Significantly larger body surface area (BSA)-adjusted left and right coronary artery dimensions were observed in SLE patients compared to controls (p < 0.001).
- Age at diagnosis, BMI, and serum UA and creatinine levels were associated with coronary artery diameters.
- Multivariate analysis confirmed serum UA level, age at diagnosis, and BMI as consistent predictors of coronary artery dimensions (p < 0.05 for all).
Conclusions:
- Children with paediatric-onset SLE exhibit increased coronary artery dimensions.
- Elevated serum uric acid levels are a key risk factor associated with these enlarged coronary arteries in paediatric SLE.
- Further research is needed to elucidate the underlying pathogenic mechanisms.
Objectives:
This study aimed to evaluate increased coronary artery dimensions in patients with paediatric-onset systemic lupus erythematosus (SLE) in comparison with healthy controls, and to identify risk factors associated with increased coronary artery dimensions in the SLE patients.
Methods:
As part of a longitudinal cohort study of coronary artery disease (CAD) in paediatric-onset SLE, 83 children with SLE and 36 healthy controls were enrolled for a cross-sectional analysis. Their coronary artery diameters were measured by echocardiography while their body mass index (BMI), blood pressure, and other cardiovascular factors were recorded. The age at diagnosis, serum uric acid (UA) and creatinine levels, and other lupus-related factors were further evaluated in SLE patients. Data were analysed using linear regression.
Results:
Mean body surface area (BSA)-adjusted dimensions of the left coronary artery (LCA) and right coronary artery (RCA) were significantly larger in SLE patients than in controls (both p < 0.001). The age at diagnosis, BMI, and serum UA and creatinine levels were associated with LCA and RCA diameters. There were no correlations between the coronary artery diameters and blood pressure, SLE duration, SLE Disease Activity Index (SLEDAI), C-reactive protein (CRP), C3, C4, anti-double-stranded-DNA (anti-dsDNA), or lipid profile. In multivariate analysis, serum UA level, age at diagnosis, and BMI were consistently associated with coronary artery dimensions (p < 0.001, p = 0.008, and p = 0.006 for LCA; p = 0.020, 0.013, and 0.008 for RCA).
Conclusions:
Increased coronary artery diameters were found in children with SLE and were associated with higher serum UA levels. The pathogenic mechanisms warrant further investigation.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
